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Introduction:  The  results  of  total  hip  arthroplasty  (THA)  in  congenital  dislocation  of the hip  (CDH)  are
well  known,  but such  is not  the  case  for  the  impact  of prior  conservative  surgery  on  THA  function  and
survivorship.  The  present  study  compared  THA  in CDH  with  prior  conservative  bone  surgery  (BS  group)
versus  no prior  bone  surgery  (NBS  group),  to (1)  assess  the  impact  of prior  conservative  surgery  on
function  and  survivorship  after  THA,  and (2)  determine  whether  a particular  type  of conservative  surgery
affected  function  or survivorship.
Hypothesis:  Prior  conservative  surgery  for CDH  does not  affect  function  or survivorship  of  subsequent
THA.
Patients  and  methods:  A  multicenter  retrospective  case-control  study  analyzed  430 THAs  in  CDH  patients
(332  patients:  269  female,  63 male;  mean  age,  56  years  [range,  17–80  years])  at a mean  13.2 ±  5.4 years’
follow-up  (range,  1–29  years).  The  BS  group  included  159 hips  (37%)  (64  pelvic,  81 femoral  and  14 com-
bined  pelvic  and  femoral  osteotomies),  and  the  NBS  group  271  (63%).  Groups  were  comparable  for  gender,
age at surgery,  Devane  activity  score,  preoperative  Postel  Merle  d’Aubigné  (PMA)  functional  score  and
CDH radiographic  type  following  Crowe.
Results:  At follow-up,  PMA  scores  were  comparable:  BS,  16.8  ±  1.4 (11–18);  NBS,  16.9  ±  1.5  (7–18).
Fifteen-year  survivorship  censored  for  implant  revision  for whatever  reason  did not  signiﬁcantly  dif-
fer: BS,  87%  (95%  CI: 83–91%);  NBS,  89%  (95%  CI: 86–92%).  Ten-year  survivorship  on  the  same  criterion
did  not  signiﬁcantly  differ  according  to  type  of  prior  surgery:  hip  shelf  arthroplasty,  97%  (95%  CI: 95–99%);
Chiari  osteotomy,  100%;  femoral  osteotomy,  95%  (95%  CI:  92–98%);  and  Milch  osteotomy  96%  (95%  CI:
93–99%).
Discussion/Conclusion:  Conservative  surgery  for CDH  does  not  impair  the  functional  results  or  survivor-
ship  of  subsequent  THA.
Level  of evidence:  III, case-control  study.∗ Corresponding author. Service d’orthopédie C, département universitaire de
hirurgie orthopédique et de traumatologie, hôpital Salengro, CHRU de Lille, place
e  Verdun, 59037 Lille, France. Tel.: +33 32 04 46 828; fax: +33 32 04 46 607.
E-mail address: hemigaud@nordnet.fr (H. Migaud).
http://dx.doi.org/10.1016/j.otsr.2014.07.016
877-0568/© 2014 Elsevier Masson SAS. All rights reserved.© 2014  Elsevier  Masson  SAS.  All  rights  reserved.
1. Introduction
Long-term outcome is well known in total hip arthroplasty
(THA) for congenital dislocation of the hip (CDH) [1–3]. Most
reports highlight the importance of hip alignment [2–5]. Several
series have included hips that had undergone prior conservative
surgery, but none analyzed its impact on THA outcome [1–3].
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Table  1
Types of prior surgery in the Bone Surgery (BS) group.
n
Pelvic bone surgery 64
Hip shelf 46
Chiari osteotomy 16
Salter osteotomy 2
Femoral bone surgery 81
Milch osteotomy 36
Other femoral osteotomy 45
Pelvic plus femoral bone surgery 14
Shelf + Milch 1
Shelf + femoral osteotomy 4
Chiari + femoral osteotomy 6
Salter + femoral osteotomy 1
Chiari + shelf 1
n
T
S
o
a
d
f
p
o
d
[
b
c
c
s
c
S
•
•
2
2
o
b
i
b
e
7
h
o
p
(
w
[
2
e
t
FFemoral osteotomy + arthrodesis 1
 = 159 hips.
he 2007 symposium of the French Orthopedic and Traumatologic
urgery Society (SoFCOT) devoted to arthroplasty in under 30-year-
lds identiﬁed prior surgery, and femoral osteotomy in particular,
s a factor of earlier revision surgery [6]. These ﬁndings, however,
id not focus exclusively on the sequelae of CDH, which accounted
or only 10% of indications [6]. Several other studies reported that
rior osteotomy for hip dysplasia had little or no impact on THA
utcome [7–10], but most of these cases of dysplasia involved non-
islocated or at most subluxated hips. Only Eskelinen et al. series
11] exclusively concerned THA after Schanz osteotomy for CDH,
ut had no control group.
The principal objective of the present study was to use a case-
ontrol design, comparing THA in CDH with versus without prior
onservative bone surgery, to assess the impact of conservative
urgery on THA function and survivorship. The hypothesis was that
onservative surgery would not affect THA function or survivorship.
econdary objectives were:
to determine whether a particular type of conservative surgery
affected THA function or survivorship;
to determine whether rates of complication and surgical revision
were affected by prior conservative surgery.
. Material and methods
.1. Patients
A multicenter retrospective study analyzed a continuous series
f 430 THAs (332 patients: 269 female, 63 male) in CDH operated on
etween 1983 and 2001. Prior bone surgery had been performed
n 159 hips (37%: bone surgery [BS] group) and not in 271 (63%: no
one surgery [NBS] group). Forty-six of the 98 patients with bilat-
ral THA had had prior osteotomy (21 unilateral, 25 bilateral: i.e.,
1 hips) and 52 not. Eighty-eight of the 234 unilateral THA patients
ad had prior osteotomy and 146 not.
Sixty-four of the 159 BS group hips (40%) had had pelvic
steotomies, 81 (51%) femoral osteotomies and 14 (9%) pelvic
lus femoral osteotomies (Table 1). Preoperatively, the BS group
159 hips, 128 patients) and NBS group (271 hips, 204 patients)
ere comparable for gender, age at surgery, Devane activity score
12] and Charnley hip score [13] (Table 2).
.2. Surgical methodThe surgical approach was trochanteric in 219 cases, anterolat-
ral in 51, transfemoral according to Pont L’Abbé (mostly through
he former Milch osteotomy) in 27 [14] and posterolateral in 78.
emoral osteotomy for stem insertion was required in 64 cases, Surgery & Research 100 (2014) 733–737
with greater frequency in the femoral BS subgroup (42%) than
in the rest of the series without prior femoral osteotomy (11%)
(P < 0.0001). Likewise, acetabular reconstruction was required in
221 cases, with greater frequency in the pelvic BS subgroup (80%
versus 62%: P = 0.009). Dysplasia grade on the Crowe classiﬁcation
[15] correlated strongly with rates of complementary bone surgery
associated to THA implantation:
• at the time of THA insertion pelvic surgery rates were 55% for
grade I, 74% for grade II, 85% for grade II and 54% for grade IV
(P < 0.0001);
• similarly femoral surgery rates were 3% for grade I, 6% for grade
II, 10% for grade III and 41% for grade IV (P < 0.0001).
2.3. Assessment
Patients were assessed at a mean 13.2 ± 5.4 years’ follow-up
(range, 1–29 years), with a consultation and radiography scheduled
for the study. In all, 337 hips were assessed clinically and radio-
graphically and 16 by telephone or mail; 35 patients had died and
42 were lost to follow-up. Functional assessment comprised Postel
Merle d’Aubigné (PMA) [16] and Harris [17] scores; preoperative
scores did not signiﬁcantly differ between groups (Table 3). Like-
wise, there was  no signiﬁcant difference in preoperative range of
motion except for extension, which was greater in the NBS group
(Table 3), accounting for the correspondingly higher PMA  motion
score (Table 3). Postoperative neurologic complications, implant
dislocations, revision surgeries and implant replacements were
noted. Hip position was  classiﬁed following Crowe et al. [15]. THA
outcome was  assessed as PMA  score gain.
2.4. Statistics
Data were entered in an ExcelTM spreadsheet (MicrosoftTM, Red-
mond, WA,  USA) and analyzed on JMP  software (SAS, Cary, NC,
USA). Chi2 and Fisher Exact tests were used for intergroup compar-
ison of quantitative variables (gender, Crowe CDH grade, Devane
and Charnley scores, revision and complications rates). Analysis of
variance and Kruskall and Wallis tests were used to compare mean
values between groups and between preoperative and follow-up
status (age, BMI, Harris and PMA  scores and PMA  score gain).
Finally, survivorship analysis was  performed with any revision
surgery leading to implant change as end point, with 95% conﬁ-
dence intervals, analysis stopping in the last interval containing
at least 30 hips; survivorship was  compared on log-rank test. The
ﬁrst-order risk threshold was set at 5%.
3. Results
PMA  and Harris scores for the 430 hips showed signiﬁcant
improvement: PMA  score rose from 9.8 ± 2.8 (2–17) to 16.9 ± 1.5
(7–18), P < 0.0001; Harris score rose from 45.8 ± 15.5 (2–85) to
75.4 ± 25.1 (11–100), P < 0.0001. At last follow-up, they did not
signiﬁcantly differ between groups (Table 3). Likewise, PMA  score
gain did not signiﬁcantly differ between groups: BS, 7.2 ± 3 (–1 to
14); NBS, 7.1 ± 2.7 (0 to 17); P = 0.4. Although there was preopera-
tively a mean 4◦ extension deﬁcit in the BS group, ranges of motion
did not signiﬁcantly differ at follow-up (Table 3). Location of prior
bone surgery did not affect follow-up PMA  score: pelvis, 16.8 ± 1.6;
femur, 16.9 ± 1.2; femur plus pelvis, 16.7 ± 1.4; and no osteotomy,
16.9 ± 1.5 (P = 0.8). In contrast, mean PMA  score at follow-up was
signiﬁcantly poorer after prior Milch osteotomy (16.4 ± 1 [14–18])
or hip shelf arthroplasty (16.5 ± 1.6 [12–18]) than after femoral
osteotomy (17.3 ± 1.2 [13–18]) or Chiari osteotomy (17.1 ± 1.6
[11–18]) (P = 0.04).
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Table  2
Comparison of the 2 congenital dislocations of the hip (CDH) groups with prior bone surgery (BS, n = 159 hips and 128 patients) without (NBS, n = 271 hips and 204 patients)
on  anthropometric and preoperative data.
BS NBS P
Gender (sex ratio) 109 F, 19 M (0.14) 160 F, 44 M (0.21) P = 0.1
Age  at surgery (years) 55 ± 12 (17–75) 57 ± 10 (18–80) P = 0.07
Body  mass index 23.9 ± 3.8 (16–38) 24.5 ± 4.4 (14–47) P = 0.1
Crowe  CDH type [15] (n = 430) P = 0.5
I  29 (20%) 56 (23%)
II  35 (24%) 62 (26%)
III  32 (22%) 40 (16%)
IV  49 (34%) 83 (35%)
Missing data (14) (30)
Devane activity score [12] (n = 332) P = 0.1
I  6 (5%) 10 (5%)
II  18 (14%) 22 (11%)
III  31 (25%) 75 (39%)
IV  48 (38%) 57 (30%)
V  22 (18%) 29 (15%)
Missing data (3) (11)
Charnley score [13] (n = 332) P = 0.6
A  61 (58%) 71 (38%)
B  38 (36%) 71 (58%)
C  7 (6%) 11 (6%)
Missing data (22) (51)
NBS: no prior bone surgery; BS: bone surgery.
Table 3
Comparison of functional results in the 2 groups of congenital dislocation of the hip: BS (n = 159 hips) with prior bone surgery, and NBS (n = 271 hips) without.
BS NBS P
Preoperative global PMA  score [16] 9.7 ± 2.8 (2–16) 9.9 ± 2.7 (4–17) P = 0.4
Missing data (1) (22)
Preoperative PMA  pain score 2.8 ± 1.2 (0–6) 2.7 ± 1.1 (0–5) P = 0.3
Preoperative PMA  walking score 3.6 ± 1.8 (0–6) 3.7 ± 1.8 (0–6) P = 0.5
Preoperative PMA  motion score 3.2 ± 1 (0–6) 3.4 ± 1.1 (1–6) P = 0.03a
PMA  score [16] at follow-up 16.8 ± 1.4 (11–18) 16.9 ± 1.5 (7–18) P = 0.4
Missing data (7) (26)
PMA  pain score at follow-up 5.7 ± 0.7 (0–6) 5.7 ± 0.5 (3–6) P = 0.5
PMA  walking score at follow-up 5.4 ± 0.9 (1–6) 5.4 1 (0–6) P = 0.5
PMA  motion score at follow-up 5.7 ± 0.5 (3–6) 5.7 ± 0.6 (2–6) P = 0.7
Preoperative Harris score [17] 46.6 ± 14.9 (5–85) 45.3 ± 15.9 (2–79) P = 0.4
Missing data (15) (39)
Harris  score [17] at follow-up 73.1 ± 25.6 (22–100) 77 ± 24.7  (11–100) P = 0.1
Missing data (29) (81)
Preoperative range of motion (degrees)
Missing data (1) (24)
Flexion 66 ± 27 (–45–140) 68 ± 26 (5–140) P = 0.3
Extension 6 ± 10 (–50–45) 10 ± 12 (–45–5) P = 0.001a
Abduction 12 ± 12 (–20–45) 11 ± 13 (–30–60) P = 0.5
Adduction 9 ± 10 (–10–40) 10 ± 11 (–20–50) P = 0.2
External rotation 17 ± 14 (–20–80) 17 ± 15 (–30–60) P = 0.7
Internal rotation 5 ± 20 (–60–80) 7 ± 21 (–40–80) P = 0.1
Range of motion at follow-up (degrees)
Missing data (5) (25)
Flexion 99 ± 17 (45–140) 101 ± 20 (80–140) P = 0.1
Extension −0.4 ± 3.5 (–30–10) −1 ± 5 (–40–10) P = 0.2
Abduction 25 ± 9 (1–50) 26 ± 10 (0–60) P = 0.4
Adduction 16 ± 8 (0–40) 18 ± 9 (–10–30) P = 0.1
External rotation 23 ± 9 (0–60) 23 ± 10 (0–60) P = 0.9
Internal rotation 17 ± 11 (0–60) 18 ± 13 (–10–60) P = 0.3
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a Indicates signiﬁcant difference.
There were 14 early dislocations (3.2%), mainly associated with a
rochanteric approach (13/219), none with an anterolateral (n = 51)
r transfemoral Pont L’Abbé approach (n = 27), and 1 with a postero-
ateral approach (n = 78). Prior conservative surgery did not affect
he rates of dislocation (BS, n = 7 (3.7%); NBS, n= 7 (2.6%); P = 0.5)
r neurologic complication (6 sciatic and 6 femoral nerve palsies,
f which 4 (2.5%) in the BS group and 8 (2.9%) in the NBS group;
 = 0.7).
Sixty-two cases required revision surgery. Fifty-six implant revi-
ion procedures (34 of both components and 22 of either the cup orubigné Hip score [16].
the stem) were performed: 7 for wear, 5 for dislocation, 4 for infec-
tion, 1 for femoral non-union, 1 for cup malpositioning, 2 for stem
fracture, and 36 for loosening of one or both components. Six revi-
sion osteosyntheses were performed for non-union of the greater
trochanter. Revision rates were comparable in the BS group (n = 27;
16.9%) and the NBS group (n = 35; 12.9%) (P = 0.3).Fifteen-year survivorship with surgical revision for implant
change for whatever reason as end point was  87% (95% CI: 83–91%)
in the BS group and 89% (95% CI: 86–92%) in the NBS group (P = 0.08).
For the femoral component, it was 88% (95% CI: 83–93%) with
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ormer femoral osteotomy versus 91% (95% CI: 89–93%) with-
ut (P = 0.3); and for the cup, 90% (95% CI: 86–94%) with former
cetabular surgery versus 92% (95% CI: 90–94%) without (P = 0.1).
en-year survivorship for the two components with implant revi-
ion for whatever reason as end point was comparable whatever the
rior conservative procedure: 97% (95% CI: 95–99%) for hip shelf
rthroplasty, 100% after Chiari osteotomy, 95% (95% CI: 92–98%)
fter femoral osteotomy and 96% (95% CI: 93–99%) after Milch
steotomy, versus 98% in the NBS group (95% CI: 97–99%) (P = 0.7)
excluding 3 Salter osteotomies).
. Discussion
The study hypothesis was conﬁrmed: conservative CDH surgery
id not impair either functional results or survivorship in subse-
uent THA. Clinical gain in the two groups was not signiﬁcantly
ifferent. Acetabular or femoral bone surgery during THA was more
requent in case of prior conservative surgery, in agreement with
oos et al. [18].
Despite its very large cohort of THA following CDH, the present
tudy involved some limitations:
it was a multicenter study; however, all surgery was performed
by experienced operators, with a shared strategy of placing the
cup in the original true acetabulum;
it was retrospective, and some data were missing; the rate, how-
ever, was less than 10% for the main variables (PMA score, 7%;
age, 0%; gender, 0%; prior conservative surgery or not, 0%; range of
motion, 6%; Devane score, 3%) and 10–20% for secondary variables
(Harris score, Crowe grade, Charnley score, surgical approach).
Moreover, the long follow-up enhanced reliability, especially for
the survivorship curves, which were calculated from a minimum
of 30 hips in the last interval;
the multi-observer design may  have led to some differences in
assessment; the variables considered, however, were robust and
well-established: PMA  score, and revision for change of THA com-
ponent for whatever reason.
The present results diverge from those of the 2007 SoFCOT sym-
osium, which reported poorer THA survivorship in hips previously
perated on in childhood [6]. However, the present population was
ifferent: only 10% of the symposium cases were CDH, whereas
he present cohort included only subluxated or dislocated hip. The
resent 15-year survivorship, on the other hand, is in agreement
ith Murayama et al. [3], reporting a smaller series of 68 hips.
hougle et al. [19] reported that the cup was at greater risk of revi-
ion in case of THA on CDH, with only 63% 20-year survivorship, and
hat prior surgery further reduced this rate. The present study did
ot conﬁrm such ﬁndings, on a larger series (430 versus 292) with
omparable follow-up (13.2 versus 15.7 years). Above all, Chougle
t al. series [19] included offset-bore cups. In series of cemented
r non-cemented THA with non-offset cups, results are compara-
le to the present series: 94.7% at 13 years for Flecher et al. [20],
3% at 10 years for Karachalios et al. [21], and 93% at 10 years for
bolghasemian et al. [22] for THA following CDH that had prior hip
helf arthroplasty.
Functional results were overall comparable between the BS and
BS groups; at a more detailed level, however, clinical results for
HA after Milch osteotomy and hip shelf arthroplasty were poorer
han after femoral or Chiari osteotomy. It is easy to see how the
ifﬁculty of conversion from the Milch procedure could impair the
unctional results of THA [11]. In contrast, unless there is some con-
ounding factor we have failed to identify, it is harder to account for
he poorer results found after hip shelf arthroplasty, which alters
one architecture less than femoral or pelvic osteotomy [7–10,22]. Surgery & Research 100 (2014) 733–737
Conversely, none of the prior procedures reduced survivorship
compared to the NBS group, in agreement with most studies of dys-
plasia [7,10,22]. In the present series, THA survivorship after prior
Milch osteotomy was  equal to that found in the NBS group and bet-
ter than that reported by Eskelinen et al. [11]: only 64% at 12 years,
but this was  due to wear and loosening of cementless cups.
The present complications rates (3.2% dislocation and 2.7%
palsy) were lower than Dallari et al. [23], with 12% dislocation and
9% femoral palsy after THA with CDH. Eggli et al. [24] reported a
1.5% rate of palsy, correlating with prior surgery. The present study
did not conﬁrm such ﬁndings, the palsy rate being identical in the
two groups. The present dislocation rate was  higher than in THA
for primary osteoarthritis, but seemed related not to the surgical
approach (1.2% for the reputedly more unstable posterior approach,
versus 4.6% for the trochanteric approach) so much as to technical
issues of muscle and capsular release as well as bone exposure,
independently of prior conservative surgery.
5. Conclusion
Conservative surgery performed for CDH did not impair the
functional results or survivorship of subsequent THA. Likewise, the
rate of complications (dislocation, palsy) was  not higher, although
prior pelvic and femoral osteotomy complicated implantation and
more often required reconstruction (graft, osteotomy) during THA.
In the light of these results, conservative surgery for dysplastic hip
should not be shunned as liable to impair the results of possible
subsequent THA.
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